Remove digital therapeutics Remove education Remove investment Remove VC
article thumbnail

11 investors predict a colorful, if difficult, future for psychedelic startups

TechCrunch

is discussed,” said Amy Kruse, chief investment officer, Satori Neuro. Like several investors we surveyed, Kruse doesn’t solely invest in psychedelics, but they are very much on her radar. In the meantime, pharma and big biotech VC firms are more interested in exploring the non-hallucinogenic psychedelic pathways.

startup 99
article thumbnail

Vira Health gets $12M to dial up personalized menopause support

TechCrunch

startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based based VC firm Optum Ventures, as it gears up to hop over the pond. Vira Health , a U.K.

health 86